Abstract:The first intraocular lenses (IOLs) used for cataract surgery transmitted both ultraviolet (UV) radiation and visible light to the retina. Colorless UV-blocking IOLs were introduced and rapidly adopted in the 1980s. Yellow-tinted blue-blocking (also known as blue-filtering) IOLs were marketed in the early 1990s. Blue-blocking IOLs were intended to simulate age-related crystalline lens yellowing to reduce the cyanopsia that some patients experienced after cataract surgery. When blue-filtering IOLs were introduced in North America, however, blue-blocking chromophores were advocated as a way to protect patients from age-related macular degeneration (AMD) despite the lack of evidence that normal environmental light exposure causes AMD. The "blue light hazard" is a term that describes the experimental finding that acute, abnormally intense light exposures are potentially more phototoxic to the retina when short rather than long wavelengths are used. Thus, in brief exposures to intense light sources such as welding arcs, ultraviolet radiation is more hazardous than blue light, which is more hazardous than longer wavelength green or red light. International commissions have cautioned that the blue light hazard does not apply to normal indoor or outdoor light exposures. Nonetheless, the hazard is used for commercial purposes to suggest misleadingly that ambient environmental light can cause acute retinal phototoxicity and increase the risk of AMD. Very large epidemiological studies show that blue-blocking IOLs do not reduce the risk or progression of AMD. Additionally, blue-filtering IOLs or spectacles cannot decrease glare disability, because they decrease image and glare illuminance in the same proportion. Blue light is essential for older adults' scotopic photoreception needed to reduce the risk of nighttime falling and related injuries. It is also critical for circadian photoreception that is essential for good health, sleep and cognitive performance. Unfortunately, age-related pupillary miosis, retinal rod and ganglion cell photoreceptor degeneration and decreased outdoor activity all reduce the amount of healthful blue light available to older adults. Blue-restricting IOLs further reduce the available blue light at a time when older adults need it most. Patients and ophthalmologists are exposed to hypothesis-based advertisements for blue-filtering optical devices that suppress short wavelength light critical for vision in dim lighting and for good physical and mental health. Spectacle and intraocular lens selections should be based on scientific fact, not conjecture. Ideal IOLs should improve photoreception rather than limit it permanently. Practice efficiency, surgical convenience and physician-manufacturer relationships may eliminate a patient's opportunity to choose between colorless blue-transmitting IOLs and yellow-tinted, blue-restricting IOLs. Cataract surgeons ultimately determine whether their patients have the opportunity to make an informed choice about their future photoreception.

Clinical observation of blue-light-filtering intraocular lenses implantation on treating patients with diabetes cataract

The clinical applied study of blue light absorbing intraocular lens

Evaluation of visual performance and eye movements in patients with blue light-filtering intraocular lenses versus ultraviolet light-filtering intraocular lenses

Effects of blue-light-filtering intraocular lenses on contrast sensitivity in patients with glaucoma

Comparison of Blue Light-Filtering Iols and Uv Light-Filtering Iols for Cataract Surgery: A Meta-Analysis

Clinical Study on Implantation with UV-biocking and Blue-light Filtering Intraocular Lens

Clinical efficacy of femtosecond laser-assisted phacoemulsification in diabetic cataract patients

Observation on the results of phacoemulsification extraction of diabetic cataract and implantation of artificial crystal.

Impact of blue-light filtering intraocular lens implantation on the quality of sleep in patients after cataract surgery.

Preliminary clinical results of blue light filtering intraocular lens

Clinical application analysis of phacoemulsification for diabetic cataract

Clinical Observation on Optical Coherence Tomography of Foveal Retinal Thickness after Diabetic Cataract Phacoemulsification and Foldable Intraocular Lens Implantation

The macular microstructure analysis in diabetic cataracts after phacoemulsification

Lumière bleue et implants intraoculaires : croyances et réalités

The clinical study posterior chamber intraocular lens implantation in diabetic patients

The phaco-emulsification in diabetics with cataract

Clinical Outcomes Following Trifocal Diffractive Intraocular Lens Implantation For Age-Related Cataract In China

Clinical observation of corrected super high myopia cataract with individul diopter-selected IOL

Clinical Observation of Combined Surgery for Cataract and Glaucoma:Phacoemulsification and Viscocanalostomy

Phacoemulsification and Intraocular Lens Implantation in Patients with Retinitis Pigmentosa Complicated Cataract

Clinical Observation of Iris-fixated intraocular lenses for Treating 169 High Myopia